Bridge Informatics Appoints Miguel Louzan to Board, Enhancing Data Architecture Expertise to Drive Client-Centric Solutions

Bridge Informatics Appoints Miguel Louzan to Board, Enhancing Data Architecture Expertise to Drive Client-Centric Solutions

BOSTON, MA– Bridge Informatics, a data science consultancy bridging the gap between biology and informatics in the life sciences industry, proudly announces the appointment of Miguel Louzan as its third Board of Directors member. With nearly three decades of expertise in spearheading digital and data transformations within the international pharmaceutical, biotechnology, medical device, and private equity domains, Louzan brings invaluable Information Technology (IT) leadership to the forefront of Bridge Informatics’ strategic vision.

“Miguel’s appointment marks a significant milestone for Bridge Informatics, reinforcing our dedication to delivering cutting-edge data architecture and management solutions for the life sciences industry,” said Dan Ryder, Founder and Chief Executive Officer of Bridge Informatics. “His extensive experience and profound understanding of IT’s pivotal role in shaping the future of growing life science companies make him an invaluable asset to our team.”

A stalwart in the global pharmaceutical landscape, Louzan possesses a rich history dedicated to catalyzing digital and data transformation initiatives for esteemed companies worldwide. Currently serving as the Chief Digital Information Officer at a global healthcare company, Louzan is instrumental in propelling the company’s digital evolution and championing information technology priorities, fostering company wide integration of advanced capabilities to fuel business growth and fortify cybersecurity measures. Louzan’s strategic acumen and deep-rooted expertise will be pivotal in shaping the company’s product and service offerings, ensuring they remain finely attuned to the evolving needs of clients.

“I am honored to join Bridge Informatics and contribute to its mission of empowering life science organizations through data-driven decision-making,” expressed Mr. Louzan. “The convergence of biology, bioinformatics, and IT represent a pivotal frontier in shaping the future of personalized medicine, and I am eager to leverage my experiences to drive innovation and impact within this dynamic landscape.”

Louzan previously held the esteemed position of managing director for technology transformation at a prominent private equity firm, where his expertise guided leading corporations in formulating robust digital and technology strategies. His distinguished career also includes serving as the Chief Information Officer for LifeScan, a pioneering company in diabetes care, and occupying senior IT management roles at UCB Pharma, Boston Scientific, and SWM.

For more information about Bridge Informatics, please visit Follow the company on LinkedIn, X (formerly Twitter), and Facebook.

Share this article with a friend